mucositis K05.5
Conditions
Interventions
Group 1: PerioChip®-group (PerioChip® = gelatine chip with chlorhexidine). The PerioChip® applicated arround the implant after 0 and 3 months
Group 2: Chlorhexidine-group (Curasept ADS 1% Parodontal G
Sponsors
Zentrum für ZahnmedizinKlinik für Präventivzahnmedizin, Parodontologie und Kariologie
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: • Informed Consent as documented by signature • Systemically healthy subjects • At least one dental implant with mucositis in terms of a probing pocket depth less than 5 and bleeding on probing and no obvious bone loss (< 2mm). • Ability to read and understand the patient inform
Exclusion criteria
Exclusion criteria: • Patients with untreated periodontitis • Pregnant or nursing women • Patients with antibiotic therapy within the last 6 months • Patients with periimplantitis therapy within the last 3 months • Subjects with an allergy to or chlorhexidine • Anti-coagulated patients • Periimplantitis: probing pocket depth more than 5 mm and obvious bone loss (> 2mm) • Intake of medical products containing Nystatin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome variable is bleeding-on-probing after 3 and 6 months after Baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes: Changes in the bacterial colonization (bacterial tests), a-MMP8 tests indicating the grade of collagen destruction and plaqueindex | — |
Countries
Switzerland
Contacts
Public Contactcyrill Bettschart
Dr. Mattiola und Partner AG
Outcome results
None listed